Monte Rosa Therapeutics Inc (GLUE) financials · rev $123.7M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Monte Rosa Therapeutics Inc (GLUE) rev $123.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $123.7M | $75.6M |
| Operating Income | -$54.2M | -$81.1M |
| Net Income | -$38.6M | -$72.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $448.7M | $438.7M |
| Current Assets | $393.2M | $377.4M |
| Cash & Equivalents | $129.9M | $224.3M |
| PP&E | $26.0M | $29.5M |
| Total Liabilities | $215.6M | $215.8M |
| Current Liabilities | $64.2M | $156.9M |
| Shareholders' Equity | $233.1M | $222.9M |
| Retained Earnings | -$477.2M | -$438.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$22.8M | $42.0M |
| CapEx | $4.70M | $3.99M |
| Investing Cash Flow | -$101.8M | -$44.5M |
| Financing Cash Flow | $30.4M | $98.9M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$94.3M | $96.4M |
| Free Cash Flow | -$27.5M | $38.0M |
FAQ
What is GLUE P/E and revenue?
Monte Rosa Therapeutics Inc (GLUE) rev $123.7M.
What is GLUE revenue?
Monte Rosa Therapeutics Inc last cached revenue is $123.7M (FY2025).
Is GLUE profitable?
Monte Rosa Therapeutics Inc last cached net income is -$38.6M (FY2025).
What are GLUE total assets?
Monte Rosa Therapeutics Inc last cached total assets are $448.7M (FY2025).
What is GLUE free cash flow?
Monte Rosa Therapeutics Inc last cached free cash flow is -$27.5M (FY2025).
Not investment advice. Cached statements, not a live tape.